Letrozole tablets: Clinical Trials

7 trials of Letrozole tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 unknown, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Recruiting 3, Unknown 2, Active not recruiting 1, Enrolling by invitation 1
Phase 21Unknown 1

Follow Letrozole tablets: new trials by email Literature Review of Letrozole tablets trials Research Report on Letrozole tablets

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
HRS-8080 Tablets, Letrozole tablets, Tamoxifen Citrate Tablets - Breast Cancer
Phase 3RecruitingShandong Suncadia Medicine Co., Ltd.55002026-03-042026-05-22
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
HRS-8080 Tablet, Fulvestrant injection, Exemestane tablets - Locally Advanced Breast Cancer, Metastatic Breast Cancer
Phase 3RecruitingShandong Suncadia Medicine Co., Ltd.2402025-07-232026-10-02
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study
TOL2506, Tamoxifen, Letrozole tablets - Breast Cancer
Phase 3Enrolling by invitationTolmar Inc.2502022-12-282026-10-23
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
Letrozole tablets, carboplatin AUC 5 and paclitaxel 175 mg/m2 - Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
Phase 3RecruitingEnte Ospedaliero Ospedali Galliera1322022-09-222025-01-27
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
TOL2506, Tamoxifen, Letrozole Tablets - Breast Cancer
Phase 3Active not recruitingTolmar Inc.2502021-07-012026-10-23
Letrozole in Tubal Ectopic Pregnancy
Placebos, Letrozole tablets - Tubal Pregnancy
Phase 3UnknownQueen Mary Hospital, Hong Kong2142020-12-012023-04-10
Letrozole as a Prophylaxis From GTN for Complete Mole Patients
Suction evacuation, Letrozole tablets - Gestational Trophoblastic Disease
Phase 2 / Phase 3UnknownZagazig University2002020-06-012022-07-12

Conditions studied

Breast Neoplasms (4)  ·  Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Gestational Trophoblastic Disease (1)  ·  Hydatidiform Mole (1)  ·  Pregnancy, Tubal (1)

Sponsors

Shandong Suncadia Medicine Co., Ltd. (2)  ·  Tolmar Inc. (2)  ·  Ente Ospedaliero Ospedali Galliera (1)  ·  Queen Mary Hospital, Hong Kong (1)  ·  Zagazig University (1)

Countries

Argentina (2)  ·  Brazil (2)  ·  China (2)  ·  India (2)  ·  Mexico (2)  ·  Puerto Rico (2)  ·  United States (2)  ·  Canada (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  Italy (1)

Top investigators

Andrea DeCensi, MD (1)  ·  E P Hamilton (1)  ·  Ernest H.Y. Ng, MD (1)  ·  Mohamed A Alabiad, MD (1)

Results publications

PMID 41392465